Core Viewpoint - ICICI Bank Limited (IBN) shows potential for significant upside, with a mean price target of $40 indicating a 30.8% increase from the current price of $30.58 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $1.41, indicating a consensus among analysts [2] - The lowest estimate is $39.00, suggesting a 27.5% increase, while the highest estimate is $42.00, indicating a 37.3% increase [2] - Analysts' price targets can be misleading, as they may not accurately reflect the stock's future price movements [7][10] Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding IBN's ability to report better earnings, which supports the potential for stock upside [4][11] - Over the last 30 days, two earnings estimates have been revised higher, leading to a 1.3% increase in the Zacks Consensus Estimate [12] - IBN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Kontoor Brands (KTB) shows potential for significant upside, with a mean price target of $96.57 indicating a 28.5% increase from the current price of $75.16 [1] Price Targets and Analyst Estimates - The mean estimate consists of seven short-term price targets with a standard deviation of $13.38, indicating variability among analysts [2] - The lowest estimate is $75.00, suggesting a slight decline of 0.2%, while the highest estimate is $118.00, indicating a potential surge of 57% [2] - Analysts' price targets can be misleading, as empirical research shows they often do not accurately predict stock price movements [7][10] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism regarding KTB's earnings, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 0.8%, with one estimate moving higher and no negative revisions [12] - KTB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of KTB's potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Skyward Specialty Insurance (SKWD) has shown a 7.4% increase in stock price over the past four weeks, with a mean price target of $61.4 indicating a potential upside of 25.4% from the current price of $48.96 [1] Price Targets and Analyst Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $8.06, suggesting variability in analyst predictions. The lowest estimate is $49.00 (0.1% increase), while the highest is $75.00 (53.2% increase) [2] - Analysts' price targets can be misleading, as empirical research indicates that they rarely accurately predict stock price movements [7][10] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - There is increasing optimism among analysts regarding SKWD's earnings prospects, as indicated by a positive trend in earnings estimate revisions. This trend correlates strongly with near-term stock price movements [11] - Over the last 30 days, five earnings estimates for SKWD have been revised upward, resulting in a 5.5% increase in the Zacks Consensus Estimate [12] - SKWD holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable measure of potential gains, the implied direction of price movement appears to be a useful guide for investors [14]

Group 1 - Adma Biologics (ADMA) shares have increased by 23.3% in the past four weeks, closing at $19.14, with a mean price target of $30.67 indicating a potential upside of 60.2% [1] - The average price targets range from a low of $30.00 to a high of $32.00, with a standard deviation of $1.15, suggesting a strong agreement among analysts [2] - Analysts show strong consensus on ADMA's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for ADMA's current year earnings has increased by 1.6% over the last 30 days, with no negative revisions [12] - ADMA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be entirely reliable, it does provide a useful guide for potential price movement [14]

Group 1 - First Advantage (FA) shares have increased by 5.1% over the past four weeks, closing at $13.82, with a mean price target of $17.43 indicating a potential upside of 26.1% [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $1.4, where the lowest estimate is $16.00 (15.8% increase) and the highest is $20.00 (44.7% increase) [2] - Analysts show strong agreement on FA's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for FA has increased by 8.5% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - FA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [14]

Core Viewpoint - Pharming Group N.V. (PHAR) shares have increased by 24% in the past four weeks, closing at $17.06, with a mean price target of $31 indicating a potential upside of 81.7% [1] Price Targets and Analyst Estimates - The mean estimate includes three short-term price targets with a standard deviation of $14.93, where the lowest estimate of $14.00 suggests a 17.9% decline, while the highest target of $42.00 indicates a potential surge of 146.2% [2] - A low standard deviation among price targets suggests a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about PHAR's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the last 30 days, two earnings estimates have been revised upward, leading to a 520% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - PHAR holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for potential investment [14]

Core Viewpoint - Wheaton Precious Metals Corp. (WPM) has seen an 8.7% increase in share price over the past four weeks, closing at $102.69, with a potential upside of 26.7% based on Wall Street analysts' mean price target of $130.06 [1] Price Targets - The average of 15 short-term price targets ranges from a low of $114.63 to a high of $160.00, with a standard deviation of $11.7, indicating variability among analysts [2] - The lowest estimate suggests an 11.6% increase from the current price, while the highest estimate indicates a 55.8% upside [2] Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 1.8% over the past month, with six estimates going higher and no negative revisions [12] - WPM holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, their reliability is questioned, as they can mislead investors more often than guide them [3][7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8][9] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction [9]

Core Viewpoint - Western Digital (WDC) has shown a significant price increase of 11.5% over the past four weeks, with a mean price target of $175.64 indicating a potential upside of 25.3% from the current trading price of $140.23 [1] Price Targets and Estimates - The mean estimate consists of 22 short-term price targets with a standard deviation of $29.75, indicating variability among analysts. The lowest estimate is $95.00, suggesting a potential decline of 32.3%, while the highest estimate is $250.00, indicating a potential increase of 78.3% [2] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9] Earnings Estimates - Analysts are optimistic about WDC's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher. This trend has shown a strong correlation with near-term stock price movements [11] - Over the last 30 days, four earnings estimates for WDC have been revised upward, resulting in a 9% increase in the Zacks Consensus Estimate [12] Zacks Rank - WDC currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors. This rank serves as a strong indicator of the stock's potential upside in the near term [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of WDC's potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Palomar (PLMR) has shown a 7% increase in stock price over the past four weeks, with a mean price target of $155.67 indicating a potential upside of 28% from the current price of $121.66 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $14.62, where the lowest estimate is $134.00 (10.1% increase) and the highest is $170.00 (39.7% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about PLMR's earnings prospects, with five estimates moving higher in the last 30 days and no negative revisions, leading to a 6% increase in the Zacks Consensus Estimate [12][11] - PLMR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as empirical research indicates that such targets often mislead investors [3][7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - SiTime (SITM) shares have increased by 1.8% recently, closing at $270.3, with a potential upside of 28.2% based on Wall Street analysts' mean price target of $346.43 [1][11] Price Targets and Analyst Estimates - The mean estimate consists of seven short-term price targets with a standard deviation of $45.16, indicating variability among analysts [2] - The lowest estimate is $260.00, suggesting a 3.8% decline, while the highest estimate is $400.00, indicating a potential 48% increase [2] - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about SITM's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 21.5% over the past month, with three estimates increasing and no negative revisions [12] - SITM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research indicates they rarely predict actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]